EMHA and Allergan

EMHA and Allergan.
Elena Ruiz de la Torre, Executive Director of EMHA attended a business meeting on 23 January with the Allergan Company.
 
The purpose of the meeting was to share ideas and priorities to explore areas of collaboration and identify opportunities between EMHA and Allergan.
We also took the opportunity to share the history of migraine with Allergan Marlow employees.
 
The attendees of the meeting focus were:
 
EMHA:  
Elena Ruiz de la Torre – Executive Director.
 
 
Allergan:   
Maria Fantis – Marketing, Neurosciences.
Gwyn Grenrock – The Allergan Foundation.
Mark Marmur – International Communications & Public Relations.
Katherine Sommer – Medical Affairs, Migraine.
Susan Stone – Global Alliance Advocacy & Patient Affairs.
Natalie Williamson – Marketing, Chronic Migraine.
 
 
 
 
 

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.

*Updated 2022: Allergan is now part of AbbVie

We discover and develop innovative medicines for tomorrow, while helping people live better lives today.

AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. 

AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech.

Since the beginning, our mission hasn’t wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers. 

Scroll to Top